Etoposide for Lymphoma

Overview
Etoposide is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat several types of cancer. It is sometimes used off-label to treat Hodgkin and non-Hodgkin lymphoma. Etoposide is sold under the brand names Etopophos, Toposar, and VePesid. It can be combined with other drugs and corticosteroids in a chemotherapy regimen to treat lymphoma.

Etoposide is an anticancer drug used in chemotherapy. Etoposide is a member of a class of drugs called plant alkaloids, and it’s also a topoisomerase II inhibitor. Etoposide is believed to work by preventing the replication of cancer cells.

How do I take it?
Etoposide is taken orally or administered as an intravenous infusion.

Side effects
Common side effects of etoposide include hair loss, mouth sores, nausea, vomiting, diarrhea, loss of appetite, low white blood cell counts, low blood pressure, early menopause in women, and loss of fertility in men or women.

Rare but serious side effects for etoposide include fetal harm in pregnant women, anaphylaxis, secondary leukemias, and increased risk for developing other cancers.

For more details about this treatment, visit:

Etoposide — Leukemia & Lymphoma Society
https://www.lls.org/drug/etoposide